{
  "subject": "Scientific description of TDAH",
  "raw": "Neurotransmitters. <[silence]> Executive function. <[silence]> Genetic predisposition. <[silence]>\n\nAttention Deficit Hyperactivity Disorder (TDAH) is characterized by persistent patterns of inattention and/or hyperactivity-impulsivity. <[silence]> This neurodevelopmental disorder manifests in childhood and often persists into adulthood. <[silence]> The symptoms are not merely behavioral but are deeply rooted in the brain's structure and function. <[silence]> Research indicates that individuals with TDAH have altered activity in the brain's frontal lobes, which are responsible for executive functions such as decision-making and impulse control. <[silence]>\n\nScientifically, TDAH is associated with dysregulation of neurotransmitters, particularly dopamine and norepinephrine. <[silence]> These chemicals play a significant role in attention and behavior regulation. <[silence]> Imaging studies have shown that people with TDAH often exhibit differences in brain connectivity and volume, particularly in areas linked to attention and impulse control. <[silence]> Genetic studies suggest a hereditary component, with multiple genes contributing to the disorder's complexity. <[silence]>\n\nThe diagnosis of TDAH is based on clinical criteria outlined in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5). <[silence]> It requires a comprehensive assessment of behavioral symptoms and their impact on daily functioning. <[silence]> While there is no single test for TDAH, a combination of interviews, questionnaires, and behavioral observations is used to confirm the diagnosis. <[silence]> Treatment typically involves a combination of medication, behavioral therapy, and lifestyle changes to manage symptoms effectively. <[silence]>\n\nThree related subjects are neurodevelopmental disorders, executive function, and neurotransmitter regulation.",
  "clean": "Neurotransmitters.  Executive function.  Genetic predisposition.  Attention Deficit Hyperactivity Disorder (TDAH) is characterized by persistent patterns of inattention and/or hyperactivity-impulsivity.  This neurodevelopmental disorder manifests in childhood and often persists into adulthood.  The symptoms are not merely behavioral but are deeply rooted in the brain's structure and function.  Research indicates that individuals with TDAH have altered activity in the brain's frontal lobes, which are responsible for executive functions such as decision-making and impulse control.  Scientifically, TDAH is associated with dysregulation of neurotransmitters, particularly dopamine and norepinephrine.  These chemicals play a significant role in attention and behavior regulation.  Imaging studies have shown that people with TDAH often exhibit differences in brain connectivity and volume, particularly in areas linked to attention and impulse control.  Genetic studies suggest a hereditary component, with multiple genes contributing to the disorder's complexity.  The diagnosis of TDAH is based on clinical criteria outlined in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5).  It requires a comprehensive assessment of behavioral symptoms and their impact on daily functioning.  While there is no single test for TDAH, a combination of interviews, questionnaires, and behavioral observations is used to confirm the diagnosis.  Treatment typically involves a combination of medication, behavioral therapy, and lifestyle changes to manage symptoms effectively.  Three related subjects are neurodevelopmental disorders, executive function, and neurotransmitter regulation.",
  "timestamp": "20251109T223306Z"
}